Woodmont Investment Counsel’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,188
| Closed | -$1.42M | – | 265 |
|
|
2024
Q3 | $1.42M | Buy |
21,188
+8,218
| +63% | +$549K | 0.11% | 115 |
|
|
2024
Q2 | $1.54M | Sell |
12,970
-2,166
| -14% | -$257K | 0.13% | 107 |
|
|
2024
Q1 | $1.61M | Buy |
15,136
+70
| +0.5% | +$7.46K | 0.14% | 104 |
|
|
2023
Q4 | $1.5M | Buy |
15,066
+5,766
| +62% | +$573K | 0.14% | 105 |
|
|
2023
Q3 | $961K | Buy |
9,300
+960
| +12% | +$99.2K | 0.1% | 133 |
|
|
2023
Q2 | $1.01M | Sell |
8,340
-532
| -6% | -$64.6K | 0.11% | 131 |
|
|
2023
Q1 | $1.36M | Buy |
8,872
+315
| +4% | +$48.4K | 0.14% | 113 |
|
|
2022
Q4 | $1.54M | Sell |
8,557
-280
| -3% | -$50.3K | 0.17% | 106 |
|
|
2022
Q3 | $1.05M | Sell |
8,837
-35
| -0.4% | -$4.14K | 0.13% | 124 |
|
|
2022
Q2 | $1.27M | Buy |
+8,872
| New | +$1.27M | 0.16% | 112 |
|